Cargando…
Mapping routine measles vaccination in low- and middle-income countries
The safe, highly effective measles vaccine has been recommended globally since 1974, yet in 2017 there were more than 17 million cases of measles and 83,400 deaths in children under 5 years old, and more than 99% of both occurred in low- and middle-income countries (LMICs)(1–4). Globally comparable,...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739806/ https://www.ncbi.nlm.nih.gov/pubmed/33328634 http://dx.doi.org/10.1038/s41586-020-03043-4 |
Ejemplares similares
-
Comparative Distributional Impact of Routine Immunization and Supplementary Immunization Activities in Delivery of Measles Vaccine in Low- and Middle-Income Countries
por: Portnoy, Allison, et al.
Publicado: (2020) -
Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries
por: Levin, Ann, et al.
Publicado: (2023) -
Improving routine childhood immunisation outcomes in low-income and middle-income countries: an evidence gap map
por: Engelbert, Mark, et al.
Publicado: (2022) -
Editorial: The Use of Routine Health Data in Low- and Middle-Income Countries
por: Todd, Jim, et al.
Publicado: (2020) -
Rotavirus vaccine protection in low-income and middle-income countries
por: Ramakrishnan, Girija, et al.
Publicado: (2019)